C. S. Sharanya

Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target

K. G. Arun, C. S. Sharanya, Dileep Francis et al. · Journal of Biomolecular Structure and Dynamics · 2020 · 90 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Repurposing simeprevir, calpain inhibitor IV and a cathepsin F inhibitor against SARS-CoV-2 and insights into their interactions with M ^pro

Dileep Francis, C. S. Sharanya, Arun K.G. et al. · Journal of Biomolecular Structure and Dynamics · 2020 · 35 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Derivatives Form Better Lipoxygenase Inhibitors than Piperine: <i>In Vitro</i> and <i>In Silico</i> Study

Muringayil Joseph Tomy, C. S. Sharanya, K.V. Dileep et al. · Chemical Biology & Drug Design · 2014 · 26 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Computational screening combined with well-tempered metadynamics simulations identifies potential TMPRSS2 inhibitors

C. S. Sharanya, D. Sasikala Wilbee, Shijulal Nelson‐Sathi et al. · Scientific Reports · 2024 · 20 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Aloe emodin shows high affinity to active site and low affinity to two other sites to result consummately reduced inhibition of lipoxygenase

C. S. Sharanya, K. G. Arun, M. Haridas · Prostaglandins & Other Lipid Mediators · 2020 · 17 citations

Life Sciences, Biochemistry, Enzyme Mechanism +8